123 related articles for article (PubMed ID: 15721314)
1. Analysis of eluted peptides from type 1 diabetes-susceptible HLA class II molecules identified novel islet protein, heparin/heparan sulfate-interacting protein.
Nakanishi K; Komatsu Y; Kogawa N; Matsushita H
Biochem Biophys Res Commun; 2005 Apr; 329(1):356-61. PubMed ID: 15721314
[TBL] [Abstract][Full Text] [Related]
2. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
[TBL] [Abstract][Full Text] [Related]
3. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells.
Moustakas AK; Papadopoulos GK
Am J Med Genet; 2002 May; 115(1):37-47. PubMed ID: 12116175
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a human T cell line reactive to a 52 kDa islet protein.
Sobel DO; Fleisher T; Karounos DG
J Autoimmun; 1997 Aug; 10(4):387-94. PubMed ID: 9237802
[TBL] [Abstract][Full Text] [Related]
5. HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides.
Ellis RJ; Varela-Calvino R; Tree TI; Peakman M
Immunology; 2005 Nov; 116(3):337-46. PubMed ID: 16236123
[TBL] [Abstract][Full Text] [Related]
6. The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection.
Suri A; Unanue ER
Adv Immunol; 2005; 88():235-65. PubMed ID: 16227092
[TBL] [Abstract][Full Text] [Related]
7. The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
Vartdal F; Johansen BH; Friede T; Thorpe CJ; Stevanović S; Eriksen JE; Sletten K; Thorsby E; Rammensee HG; Sollid LM
Eur J Immunol; 1996 Nov; 26(11):2764-72. PubMed ID: 8921967
[TBL] [Abstract][Full Text] [Related]
8. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.
Raddrizzani L; Sturniolo T; Guenot J; Bono E; Gallazzi F; Nagy ZA; Sinigaglia F; Hammer J
J Immunol; 1997 Jul; 159(2):703-11. PubMed ID: 9218585
[TBL] [Abstract][Full Text] [Related]
9. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase.
Kwok WW; Domeier ML; Raymond FC; Byers P; Nepom GT
J Immunol; 1996 Mar; 156(6):2171-7. PubMed ID: 8690906
[TBL] [Abstract][Full Text] [Related]
10. Proteomic identification of an MHC-binding peptidome from pancreas and breast cancer cell lines.
Antwi K; Hanavan PD; Myers CE; Ruiz YW; Thompson EJ; Lake DF
Mol Immunol; 2009 Sep; 46(15):2931-7. PubMed ID: 19615748
[TBL] [Abstract][Full Text] [Related]
11. A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus.
Ettinger RA; Kwok WW
J Immunol; 1998 Mar; 160(5):2365-73. PubMed ID: 9498778
[TBL] [Abstract][Full Text] [Related]
12. [Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases].
Nishimura Y
Nihon Rinsho; 1997 Jun; 55(6):1384-96. PubMed ID: 9200922
[TBL] [Abstract][Full Text] [Related]
13. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes.
Ouyang Q; Standifer NE; Qin H; Gottlieb P; Verchere CB; Nepom GT; Tan R; Panagiotopoulos C
Diabetes; 2006 Nov; 55(11):3068-74. PubMed ID: 17065344
[TBL] [Abstract][Full Text] [Related]
14. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.
Suri A; Walters JJ; Gross ML; Unanue ER
J Clin Invest; 2005 Aug; 115(8):2268-76. PubMed ID: 16075062
[TBL] [Abstract][Full Text] [Related]
15. Low abundance of naturally processed T-cell determinants following antigen pulsing of antigen-specific human B-cell lines.
Moore SE; Schofield JP; Watts C
Immunology; 1995 Aug; 85(4):523-30. PubMed ID: 7558144
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of naturally processed peptides bound to HLA-DR4, DR53 (DRB1*0405, DRB4*0101)].
Kinouchi R; Katagiri M
Hokkaido Igaku Zasshi; 1995 Jan; 70(1):175-81. PubMed ID: 7744365
[TBL] [Abstract][Full Text] [Related]
17. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
Kropshofer H; Max H; Halder T; Kalbus M; Muller CA; Kalbacher H
J Immunol; 1993 Nov; 151(9):4732-42. PubMed ID: 8409432
[TBL] [Abstract][Full Text] [Related]
18. Modulatory role of DR4- to DQ8-restricted CD4 T-cell responses and type 1 diabetes susceptibility.
Ge X; Piganelli JD; Tse HM; Bertera S; Mathews CE; Trucco M; Wen L; Rudert WA
Diabetes; 2006 Dec; 55(12):3455-62. PubMed ID: 17130492
[TBL] [Abstract][Full Text] [Related]
19. Identification of HLA-DRB1-bound self-peptides following measles virus infection.
Ovsyannikova IG; Johnson KL; Naylor S; Poland GA
J Immunol Methods; 2005 Feb; 297(1-2):153-67. PubMed ID: 15777939
[TBL] [Abstract][Full Text] [Related]
20. Recognition of endogenously synthesized HLA-DR4 restricted HCV epitopes presented by autologous EBV transformed B-lymphoblastoid cell line.
Yang M; Zhu F; Sønderstrup G; Eckels DD
Vaccine; 2005 Jan; 23(7):951-62. PubMed ID: 15603898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
